Boundless Bio, Inc.
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.20M | -61.76M | -64.39M | -65.69M | -65.36M |
| Total Depreciation and Amortization | 1.25M | 1.24M | 1.19M | 1.14M | 1.09M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.82M | 6.90M | 6.73M | 5.98M | 5.11M |
| Change in Net Operating Assets | 3.46M | 1.51M | 1.28M | -1.02M | -1.68M |
| Cash from Operations | -46.66M | -52.12M | -55.19M | -59.60M | -60.84M |
| Capital Expenditure | -546.00K | -588.00K | -1.06M | -2.51M | -2.54M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.35M | 27.24M | 39.36M | -38.67M | -23.57M |
| Cash from Investing | 37.80M | 26.65M | 38.31M | -41.18M | -26.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 141.00K | 230.00K | 230.00K | 93.11M | 93.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -13.00K | -2.37M | -3.35M |
| Cash from Financing | 141.00K | 230.00K | 217.00K | 90.75M | 89.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.72M | -25.23M | -16.67M | -10.03M | 2.88M |